Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR3 | Q9UBY5 | 5/20 | 0.71 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.71 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.62 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.62 |
| ▸ | GABBR1 | Q9UBS5 | 1/20 | 0.62 |
| ▸ | CETP | P11597 | 1/20 | 0.60 |
| ▸ | TRPM8 | Q7Z2W7 | 4/20 | 0.52 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.50 |
| ▸ | S1PR2 | O95136 | 2/20 | 0.50 |
| ▸ | S1PR4 | O95977 | 2/20 | 0.50 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.50 |
| ▸ | S1PR3 | Q99500 | 2/20 | 0.50 |
| ▸ | FDPS | P14324 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL970167 | 1.00 | LPAR3 (0.71) | LPAR3LPAR2GABBR2GABRR1GABBR1 | |
| SCHEMBL970909 | 1.00 | LPAR3 (0.71) | LPAR3LPAR2GABBR2GABRR1GABBR1 | |
| SCHEMBL98417 | 1.00 | LPAR3 (0.71) | LPAR3LPAR2GABBR2GABRR1GABBR1 | |
| SCHEMBL6227726 | 1.00 | LPAR3 (0.71) | LPAR3LPAR2GABBR2GABRR1GABBR1 | |
| SCHEMBL970701 | 1.00 | LPAR3 (0.71) | LPAR3LPAR2GABBR2GABRR1GABBR1 | |
| SCHEMBL7095448 | 1.00 | LPAR3 (0.71) | LPAR3LPAR2GABBR2GABRR1GABBR1 | |
| SCHEMBL5984044 | 1.00 | LPAR3 (0.71) | LPAR3LPAR2GABBR2GABRR1GABBR1 | |
| SCHEMBL971961 | 1.00 | LPAR3 (0.71) | LPAR3LPAR2GABBR2GABRR1GABBR1 | |
| SCHEMBL968792 | 1.00 | LPAR3 (0.71) | LPAR3LPAR2GABBR2GABRR1GABBR1 | |
| SCHEMBL230186 | 1.00 | LPAR3 (0.71) | LPAR3LPAR2GABBR2GABRR1GABBR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 737 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4165117-B1 | FLAME RETARDANT-STABILIZER COMBINATION FOR THERMOPLASTIC POLYMERS | CLARIANT INT LTD (CH) | 2026-01-21 | — | — | EP | claimed |
| EP-3487956-B1 | FLAME PROTECTION AGENT MIXTURES, THEIR PREPARATION AND THEIR USE | CLARIANT INT LTD (CH) | 2026-01-14 | — | — | EP | claimed |
| EP-3655475-B1 | FLAME-RETARDANT GRAY POLYAMIDE COMPOSITIONS AND USE THEREOF | CLARIANT INT LTD (CH) | 2026-01-14 | — | — | EP | claimed |
| EP-3512910-B1 | FLAME RETARDANT-STABILIZER COMBINATION FOR THERMOPLASTIC POLYMERS | CLARIANT INT LTD (CH) | 2025-12-17 | — | — | EP | claimed |
| EP-3665218-B1 | FLAME-RETARDANT POLYAMIDE COMPOSITIONS AND USE THEREOF | CLARIANT INT LTD (CH) | 2025-04-02 | — | — | EP | claimed |
| EP-3679090-B1 | FLAME-RETARDANT POLYESTER COMPOSITIONS AND USE THEREOF | CLARIANT INT LTD (CH) | 2025-02-26 | — | — | EP | claimed |
| US-12234345-B2 | Flame retardant-stabilizer combination for thermoplastic polymers | CLARIANT INTERNATIONAL LTD (CH) | 2025-02-25 | — | — | US | claimed |
| EP-3665219-B1 | FLAME-RETARDANT POLYAMIDE COMPOSITIONS AND USE THEREOF | CLARIANT INT LTD (CH) | 2025-02-12 | — | — | EP | claimed |
| US-20250026771-A1 | ALUMINUM DIETHYLPHOSPHINATE CRYSTAL WITH LOW FINE POWDER CONTENT, PREPARATION METHOD THEREFOR AND USE THEREOF | JIANGSU LISIDE NEW MAT CO LTD (CN) | 2025-01-23 | — | — | US | claimed |
| CN-115551933-B | Improved polyether esters | 杜邦聚合物公司 | 2024-10-25 | — | — | CN | claimed |
| WO-2016150846-A1 | FLAME RETARDANT MIXTURES AND PRODUCTION THEREOF | CLARIANT INTERNATIONAL LTD (CH) | 2016-09-29 | — | — | WO | claimed |
| EP-2791151-B1 | MIXTURES OF DIALKYLPHOSPHINIC ACIDS AND ALKYLPHOSPHONIC ACIDS, A PROCESS FOR PREPARATION THEREOF AND USE THEREOF | CLARIANT INT LTD (CH) | 2016-09-07 | — | — | EP | claimed |
| US-20150005421-A1 | Mixtures Of Diphosphinic Acids And Dialkylphosphinic Acids, A Process For The Preparation Thereof And The Use Thereof | CLARIANT FINANCE (BVI) LIMITED (VG) | 2015-01-01 | — | — | US | claimed |
| EP-2791152-A1 | MIXTURES OF DIPHOSPHINIC ACIDS AND DIALKYLPHOSPHINIC ACIDS, A PROCESS FOR THE PREPARATION THEREOF AND THE USE THEREOF | Clariant Finance (BVI) Limited (VG) | 2014-10-22 | — | — | EP | claimed |
| EP-2791151-A1 | MIXTURES OF DIALKYLPHOSPHINIC ACIDS AND ALKYLPHOSPHONIC ACIDS, A PROCESS FOR PREPARATION THEREOF AND USE THEREOF | Clariant Finance (BVI) Limited (VG) | 2014-10-22 | — | — | EP | claimed |
| US-20140309340-A1 | Mixtures Of Dialkylphosphinic Acids And Alkylphosphinic Acids, A Process For Preparation Thereof And Use Thereof | CLARIANT FINANCE (BVI) LIMITED (VG) | 2014-10-16 | — | — | US | claimed |
| WO-2013087180-A1 | MIXTURES OF DIALKYLPHOSPHINIC ACIDS AND ALKYLPHOSPHONIC ACIDS, A PROCESS FOR PREPARATION THEREOF AND USE THEREOF | CLARIANT INTERNATIONAL LTD (CH) | 2013-06-20 | — | — | WO | claimed |
| WO-2013087179-A1 | MIXTURES OF DIPHOSPHINIC ACIDS AND DIALKYLPHOSPHINIC ACIDS, A PROCESS FOR THE PREPARATION THEREOF AND THE USE THEREOF | CLARIANT INTERNATIONAL LTD (CH) | 2013-06-20 | — | — | WO | claimed |
| EP-1449872-A1 | Stabilisation of polymeric materials | CLARIANT INTERNATIONAL LTD. (CH) | 2004-08-25 | — | — | EP | claimed |
| US-4810425-A | Preparation of phosphinic acids | ETHYL CORPORATION (US) | 1989-03-07 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250026771-A1 | ALUMINUM DIETHYLPHOSPHINATE CRYSTAL WITH LOW FINE POWDER CONTENT, PREPARATION METHOD THEREFOR AND USE THEREOF | FAR1, SLC39A11, PFAS | LPAR3 1768/4885LPAR2 1483/4885GABBR2 3478/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.